Scholarlink

<p>Lung cancer remains the leading cause of cancer death worldwide, mainly due to late diagnoses. While low-dose computed tomography (LDCT) screening reduces mortality in high-risk groups, false positives and low nodule specificity remain major challenges. High nodule prevalence even in nonsmokers further highlights the need for better risk stratification. Improved screening may be achieved through refined nodule assessment, sex-specific models, and emerging biomarkers like blood-based assays. Integrating these tools can enhance accuracy and reduce harms. Continued efforts to promote smoking cessation and improve air quality are also crucial.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lung cancer screening: advancing early detection and improving outcomes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月8日

查看全文
  • Geertruida H. de Bock

摘要

Lung cancer remains the leading cause of cancer death worldwide, mainly due to late diagnoses. While low-dose computed tomography (LDCT) screening reduces mortality in high-risk groups, false positives and low nodule specificity remain major challenges. High nodule prevalence even in nonsmokers further highlights the need for better risk stratification. Improved screening may be achieved through refined nodule assessment, sex-specific models, and emerging biomarkers like blood-based assays. Integrating these tools can enhance accuracy and reduce harms. Continued efforts to promote smoking cessation and improve air quality are also crucial.